← Back to Clinical Trials
Recruiting NCT07612995

NCT07612995 Impact of Via CT-based 3D Printing Technology on Success Rate in Endotracheal Intubation in Students

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07612995
Status Recruiting
Phase
Sponsor xiaojing wang
Condition Endotracheal Intubation
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-05
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
the course training-3Dthe course training- traditional

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-05 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this project is to develop a tracheal intubation teaching curriculum covering both normal and difficult airways using CT three-dimensional imaging and 3D printing technologies, enabling trainees to intuitively learn anatomical knowledge, operational skills, and special handling techniques, and to evaluate the learning outcomes. The research content includes the establishment of airway models and the training of students. Trainees in Group A will be trained using the tracheal intubation curriculum independently developed in this project, while trainees in Group B will be trained using traditional teaching methods, where instructors explain the course content via PowerPoint, elaborate on key and difficult points, answer student questions, and provide a summary. The teaching content for both groups is identical. After the teaching session, the teaching effectiveness will be evaluated using the second part of the teaching assessment methods.

Eligibility Criteria

Inclusion Criteria: * The only patients who were selected for the intubation were grade I and II according to the American Society of Anesthesiologists (ASA), non-obese and with good visualization of soft palate and uvula (Mallampati classification) Exclusion Criteria: * no

Contact & Investigator

Central Contact

xiaojing wang

✉ wangxiaojing@sxbqeh.com.cn

📞 18406559795

Frequently Asked Questions

Who can join the NCT07612995 clinical trial?

This trial is open to participants of all sexes, studying Endotracheal Intubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07612995 currently recruiting?

Yes, NCT07612995 is actively recruiting participants. Contact the research team at wangxiaojing@sxbqeh.com.cn for enrollment information.

Where is the NCT07612995 trial being conducted?

This trial is being conducted at Taiyuan, China.

Who is sponsoring the NCT07612995 clinical trial?

NCT07612995 is sponsored by xiaojing wang. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology